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Abstract: 
The present article reviews some recent findings on the functional ecdysone
†
 receptor which is a heterodimer of 
two proteins: ecdysone receptor (EcR) and Ultraspiracle (USP). Emphasis is given to some unique aspects of 
this receptor, in particular to its dimerization, binding to DNA, and transactivation capabilities. The effects of 
ligands (ecdysone, juvenile hormone) on these functions are discussed. In addition, perspectives on future work 
on this receptor are outlined, which are shaped by recent progress in the nuclear receptor field in general. This 
preview part of the present article concerns mainly the 3-D structure of receptor domains, the formation of large 
supramolecular receptor complexes, their influence on chromatin remodelling, receptor phosphorylation, as well 
as inter- and intramolecular cross-talks of receptor domains. 
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Abbreviations Used: Ec = ecdysone; EcR = ecdysone receptor; EcRE = ecdysone response element; JH = 
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Abstract: 
INTRODUCTION 
The present short review and preview article deals with that type of ecdysone† (Ec) receptor that is composed of 
the two proteins called EcR and USP (for ―Ec receptor‖ and ―Ultra spiracle,‖ respectively) and whose principal 
site of action is the genome. This does not exclude other putative sites of action for this receptor nor does it rule 
out the likely existence of other Ec receptor types (Tomaschko, 1999). EcR and USP are members of the 
nuclear (hormone) receptor superfamily that typically exhibit a modular structure where ligand binding, 
dimerization, and transactivation are mainly assigned to the so-called E domain while DNA binding is localized 
in the C domain (Beato, 1989). On their way from the cytoplasm to the genome, EcR and USP are postulated to 
undertake three important actions as they, first, heterodimerize, second, bind to specific DNA, and, third, 
activate nearby target genes. All three actions are suggested to be controlled by Ec. The present article follows 
EcR and USP through these three events, reporting published results of the past few years and new yet 
unpublished observations, mostly from our group. At the beginning, however, recent findings obtained with 
vertebrate members of nuclear receptor superfamily will be outlined as they may give additional important 
perspectives on future work in the Ec receptor field. 
 
 
                                               
† The term ―ecdysone‖ (Ec) rather than ―ecdysteroid‖ is used as a generic name for designating all Ec-active compounds including 
nonsteroidal Ec agonists. In the present article these compounds are: 20-hydroxyecdysone, ponasterone A, muristerone A, and 
tebufenozide (RH 5992). 
LESSONS TAUGHT BY OTHER NUCLEAR RECEPTORS 
3-D-Model of E Domain 
X-ray crystallographic analyses of isolated E domains of RXR and RAR yielded a 3-D-model, which evidently 
is also applicable to other nuclear receptors including EcR and USP (Wurtz et al., 1996). This model predicts 12 
a-helices, which includes the formation of a ligand binding pocket. Helix 10 is a major component of the 
dimerization interface. Upon ligand binding, the conformation of the E domain changes with a most 
conspicuous flipping-over of helix 12, thereby establishing a new interface to which the coactivator complex 
can bind (Glass et al., 1997; Westin et al., 1998). 
 
Coactivator Complex 
The coactivator complex consists of many proteins (Kamei et al., 1996; Torchia et al., 1997, 1998). However, 
its exact constitution at a given gene in a given cell remains to be investigated. Many proteins of the coactivator 
complex carry a so-called signature motif (LXXLL) that mediates their binding to nulcear receptors (Heery et 
al., 1997). Among these coactivator proteins, bHLH-PAS family members are of special interest since one of 
them (p160) is a dioxin receptor (Kamei et al., 1996). This opens the possibility of multiple regulation of a 
coactivator complex not only by 1 or 2 ligands to its intrinsic nuclear receptor dimer (see Westin et al., 1998) 
but in addition by ligands to other receptor types. It is intriguing that MET—a protein important for the binding 
and action of methoprene (a potent juvenile hormone analog)—also belongs to the bHLH-PAS family (Ashok et 
al., 1998; for a discussion of the JH receptor problem, see Feyereisen, 1998). Other components of the 
coactivator complex are endpoints of various signalling pathways involving different protein kinases (see 
Torchia et al., 1997, 1998). Collectively, the coactivator complex may, thus, be conceived as an integrator of a 
variety of input signals (Glass et al., 1997). Moreover, since several members of the complex have the ability to 
bind to specific sequences in DNA (beside nuclear receptors, e.g., CREB, STAT-1, JUN/FOS, see Torchia et 
al., 1997, 1998), one could imagine that the coactivator complex, as a functional unit, recognizes different sets 
of such sequences, depending on its actual protein complement. By such a combinatorial principle, a high 
specificity of target gene recognition is guaranteed. Not only the input but also the output signals of the 
coactivator complex are highly coordinated (Montminy, 1997; Torchia et al., 1998). In principle, they fulfill a 
dual role: (1) activation of the transcriptional machinery and (2) changing the structure of nearby nucleosomes. 
In fact, many of the constituents of the complex are both in one: transcription factors and specific histone acetyl 
transferases. 
 
For nuclear receptors that are already bound to their cognate response element in the non-liganded state, their 
domains accommodate a yet different protein complex, the corepressor complex. This complex, again, has a 
dual function: repression of the transcriptional machinery and histone deacetylation (Wolffe, 1997; Torchia et 
al., 1998). Upon ligand binding, the corepressor complex is exchanged with the coactivator complex. 
 
Nuclear Receptors and Chromatin Structure 
At present, it is not yet known how acetylation of specific lysine residues in histones H3 and H4 changes the 
structure of nucleosomes and chromatin. The general notion is that it facilitates transcription (Wolffe, 1997). In 
the context of previous models on Ec action and local chromatin changes (puffing; Lezzi, 1996), two points 
have to be considered regarding the role of H3 and H4  acetylation: (1) enhanced transcription is a consequence 
of changed nucleosome structure rather  than its cause; (2) the change in nucleosome structure is a consequence 
of the receptor’s binding and activation rather than their prerequisite. It,  thus, constitutes a post-receptor-binding 
event. 
 
However, there are nucleosomal changes that  must take place prior to receptor binding in order for the receptor 
to specifically recognize its response element (HRE) in nucleosomal DNA.  The major groove of the portion of 
the DNA double helix that contains the crucial contact sites of an HRE must be accessible to the receptor. This 
is the case with HREs lying in internucleosomal linker DNA or with nucleosome-attached HREs exposing their 
contact sites to the outside. However, if an HRE faces towards the nucleosomal core, its contact sites are 
inaccessible and would have to be made accessible by a change in the DNA’s rotational position on the 
nucleosome (Wong et al., 1997). Such a change represents a pre-receptor-binding event. How it is brought  about 
is still unclear and may vary with different response elements. 
 
Based on cytological and immunohistochemical work with polytene chromosomes of Chironomus tentans, an 
accessibility model has been developed for the Ec receptor (Lezzi, 1996). In the case of the chromosome region 
I-18C, accessibility is suggested to vary during development and the diurnal cycle (Lezzi et al., 1991) whereas 
with chromosome region IV-5C, it is induced by heat  shock (Lezzi, 1996). It remains to be seen whether  these 
parameters act by histone acetylation of the nucleosomal core or at a supranucleosomal level. 
 
DIMERIZATION OF ECR AND USP Effect of Ec 
In the above-described model, the ligand’s action would be restricted to an exchange of the corepressor by the 
coactivator complex. All previous steps, such as nuclear receptor dimerization,  nuclear translocation, and 
binding to DNA, would occur in a ligan d-in dependent fashion. Numerous in vitro as well as in vivo 
experiments (e.g., with EcR/USP overexpressing cells) show that EcR and  USP may in fact heterodimerize and 
bind to their response element in the absence of ligand (Thomas et al., 1993). However, it is still controversial 
whether ligand-independent dimerization also  occurs with endogenous EcR and USP under  physiological 
conditions in the living insect. Undoubtedly, Ec promotes heterodimer formation even in cell-free extracts, as 
evidenced by DNA binding assays (Thomas et al., 1993), as well as in intact tissue as suggested by 
immunological localization of endogenous EcR/USP on polytene chromosome loci after tissue culture in the 
presence or absence of Ec (Stocker et al., 1997; Lezzi,  unpublished findings). Moreover, recent two-hybrid 
studies with isolated EcR and USP E domains in yeast (Bergman, unpublished findings)  prove that the ability to 
heterodimerize resides in the E domain (plus portions of the D domain).  Apparently, heterdimerization does not 
require concomitant binding of the C domain to a bipartite recognition site in DNA. The Ec analog,  muristerone 
A, stimulates heterodimerization more than 150-fold, an effect that cannot be attributed to the transactivation 
functions (AF-1, AF-2) inherent to EcR and USP. In an attempt to  assess the importance of predicted sites for 
dimerization of EcR and USP, several truncations and  point mutations were introduced into the E domain of 
EcR. While omission of helices 11 and 12 had little effect on the constitutive level of dimerization, removal of 
helix 10 completely abolished heterodimerization capacity. Point mutations in helix 10, except for one case, 
diminished spontaneous dimerization. Much to our surprise, muristerone A-induced dimerization was affected 
by these mutations, independently of the extent of constitutive dimerization. A superinducible mutant was found 
in which the effect of muristerone A was doubled when compared to that observed with wild-type E domains. 
Since helix 10 is not  thought to contact the ligand directly, an event  lying ―downstream‖ to ligand binding must 
have been altered by the respective helix 10 mutations. 
 
Effect of Juvenile Hormone 
It has been known for a long time that juvenile hormone (JH)
‡
 quite often counteracts Ec in its effects on, e.g., 
cell proliferation and differentiation, enzyme induction, and puffing (Lezzi and Wyss, 1976; Shaaya and 
Spindler, 1990). Transactivation assays with reporter gene constructs carrying an EcRE (Berger et al., 1992; 
Lümmen, personal communication) suggest that the JH effect has its final target in the Ec-controlled 
machinery, i.e., in EcR and USP. Recent two-hybrid assays in plant cells (Crossland and Goff, 1996) and yeast 
(Bergman, unpublished results) strongly substantiate this notion as JH partially suppresses Ec-promoted 
dimerization of the E domains of EcR and USP (see above). Conversely, JH appears to promote the 
homodimerization of USP as indicated by similar types of assays (Crossland and Goff, 1996; Jones and Sharp, 
1997). These two sets of findings can be combined into a model (Fig. 1) in which an equilibrium between EcR 
and USP monomers and their various dimers is driven to the USP/USP homodimer by JH whereas Ec pushes it 
to the EcR/USP heterodimer. In the case of Ec, an actual binding to the EcR/USP complex (Yao et al., 1993) 
has been shown and implicated to be the basis of its heterodimer stabilizing action while the claimed evidence 
for an actual binding of JH to USP (Jones and Sharp, 1997) awaits further substantiation. Interactions of EcR 
                                               
‡ The term ‖juvenile hormone‖ (JH) is used in an analogous manner as ―ecdysone‖. In the present article, the JH-active compounds 
referred to are: JH III, JH bisepoxide, methoprene, methyl farnesoate, and fenoxycarb. 
and USP with other nuclear receptors (SVP, DHR3, DHR38) are not shown in this model and are not discussed 
here (Zelhof et al., 1995; White et al., 1997; Sutherland et al., 1995). 
 
An assessment of the claimed direct binding of JH to USP has been sought by mutating predicted ligand-
contacting residues in the ligand binding pocket of the E domain of USP. No change of the counteracting 
potential of JH in Ec-stimulated dimerization was observed. However, it was found that some USP mutations 
potentiated the stimulatory effect of Ec on heterodimerization (Bergman and Henrich, unpublished findings). 
Since it is believed that groups in the ligand binding pocket of EcR rather than USP are contacted by Ec, these 
USP mutations cannot directly influence Ec binding to the heterodimer and ligand-controlled 
heterodimerization. These mutations obviously do so indirectly by an unknown mechanism that resembles 
effects named ―phantom ligand effect,‖ ―transmolecular allosteric effect,‖ or ―intermolecular cross-talk‖ in the 
case of other receptors (see, e.g., Schulman et al., 1998; Westin et al., 1998; Vivat et al., 1997). 
 
DNA BINDING OF ECR/USP 
One of the most puzzling aspects of the Ec receptor is its heterodimeric nature, typical for nonsteroid receptors 
within the superfamily, and its preference for palindromic DNA sequences (PAL1, PAL0) for binding (Vögtli et 
al., 1998). Heterodimeric receptors usually prefer tandemly arranged motifs (direct repeats). However, this 
apparent paradox becomes alleviated by the fact that EcR/USP also recognizes direct repeats (DR1 up to DR12; 
Vögtli et al., 1998, and references therein). This, in turn, leaves us puzzled by the large variety of binding 
motifs, a situation that recently became accentuated by the finding of strong binding sequences that show no 
homology at all to the known consensus half site (AGGTCA) of PALs and DRs (Seibel et al., 1997; Seibel, 
unpublished data). This large array of recognized sequences indicates that the protein complex constituting the 
Ec receptor, i.e., EcR/USP, exhibits an extremely high degree of flexibility, a property that is also suggested by 
the lack of a preferred orientation of DRs in a gene’s promoter (Vögtli et al., 1998). Even though the synthetic 
PAL1 (GAGGTCAA/TTGACCTC) is bound most strongly by EcR/USP, it has never been found in nature in 
its perfect form. This is probably because natural selection does not necessarily optimize for best binding but 
rather for best control, in particular, for the option of multiple control and fine tuning. DR1, for instance, is 
recognized by USP/USP as well as by USP/EcR; the ligand dictates which type of dimer bind predominates 
(Vögtli et al., 1998). The strength of EcR/USP binding is not strictly in parallel with the strength of 
transcriptional activation. This is evidenced by a comparison of DR4 with a natural EcRE of the hsp27 gene 
(Vögtli et al., 1998). Moreover, negative control of transcription by Ec has been postulated to occur for a long 
time, i.e., with the so-called ―late Ec-controlled genes‖ (Ashburner et al., 1974). It may be that some of the 
elements lacking any resemblance to the canonic half site exert a negative transcriptional control on a nearby 
target gene when occupied by a liganded EcR/USP complex (see Towers and Freedman, 1998). 
 
 
 
TRANSACTIVATION 
Ligand-Controlled Activation Function AF-2 
As shown for a variety of nuclear receptors, the core part of the ligand-controlled transactivation function AF-2 
is located at the C-terminal end of helix 12 of the E domain, the major coactivator complex binding region 
(Masuyama et al., 1997). However, in none of the cloned EcRs and USPs has this function yet been identified, 
mapped, or characterized experimentally. There is strong circumstantial evidence, though, that it also exists in 
these members of the nuclear receptor superfamily. 
 
Ligand-Independent Activation Function AF-1 
This function usually resides in the A/B domain, at various places exhibiting no consistent sequence 
characteristics (see, e.g., Rochette-Egly et al., 1997). For the B1 isoform of EcR of Drosophila melanogaster, a 
general AF-1 has recently been mapped, by a one-hybrid approach in yeast to the very N-terminal end of the 
A/B domain (Mouillet et al., unpublished data). However, other parts of the A/B domain appear to modulate 
this transactivation function in a way that is not yet understood. 
 
EcR Isoforms Differing in AF-1 
In D. melanogaster, three EcR isoforms have been identified: B 1, B2, and A (Talbot et al., 1993).  Their 
developmental profiles as well as mutation analyses suggest different stage, tissue, and cell cycle specificities for 
each of them (reviewed by Henrich et al., 1999). We set out to investigate the molecular basis of these 
differences starting by a search for AF-1 in their A/B domains. Besides B1, only the B2 isoform appears to 
exhibit an AF-1, which, however, is weaker. Interestingly,  neither C. tentans EcR nor any of the USPs tested 
revealed an AF-1 in their A/B domain when assayed in yeast (Mouillet et al., unpublished data).  It is probably 
not fortuitous that the AF-1 with the broadest host cell compatibility is that of the B1 isoform. Homologs of the 
D. melanogaster B1 isoform of EcR have been found in almost all insect species investigated (Henrich et al., 
1999). This suggests that the A/B domain of B1, perhaps due to its very general AF-1, controls a function that is 
vital not only for insect but also for  vertebrate and yeast cells and, thus, has been conserved during evolution. 
 
CYTOPLASMIC ECR AND USP AS PUZZLE-PIECES IN LARGE COMPLEXES 
Many nuclear receptors form supramolecular  complexes in their cytoplamic state consisting of various heat 
shock proteins (HSPs), immunophilins,  and other proteins (Gehring, 1998). The existence of higher molecular 
weight complexes was also  strongly suggested for EcR by various physical analyses of cytoplasmic extracts (see, 
e.g., Turberg and Spindler, 1992). In fact, recent studies on prothoracic gland extracts of Manduca sexta reveal 
the presence of an immunophilin (FKBP46), HSP70,  and HSP90 in complexes with EcR and USP (Song  et al., 
1997; L. I. Gilbert, personal communication).  It, thus, appears that the Ec receptor follows the general behavior 
of steroid receptors although it belongs to the heterodimeric type of nuclear receptors, which are thought not to 
be complexed with HSPs (see, e.g., Dalman et al., 1990). 
 
FITTING THE PUZZLE PIECES WITH ECR AND USP DOMAINS 
As mentioned above, not all predicted functions could yet be assigned to specific domains or  subdomains of 
EcR and USP. Conversely, for several domains and subdomains, the specific role in EcR/USP functioning is 
still mysterious. This holds true particularly for USP. Is the task of USP  simply that of a ―helper‖ enabling EcR 
to bind its ligand (Ec), to recognize its response element  (EcRE), and to recruit a specific coactivator complex at 
its AF-2? Or else, does USP have its ―own rights‖ within the Ec receptor complex in terms of intrinsic functions 
performed by its own domains? Such questions are usually attacked by investigating the functional capabilities 
of isolated domains in vitro or by looking in vivo for a loss of function due to mutations in a specific domain.  A 
more subtle way of learning about a domain’s role exists in the study of chimeric receptors in which the domain 
in question is exchanged by that of another species. The rationale thereby is not to use a defective domain but 
rather one that  has proven to be functional, maybe in a slightly divergent manner. 
 
In recent experiments (Henrich et al., unpublished data) chimeras were constructed in which the E and part of 
the D domain of D. m elanogaster USP were exchanged by the homologous sequences of C. tentans. When 
introduced into D. m elanogaster embryos lacking endogenous USP, this chimera was able to rescue 
development  up to the prepupal stage, in higher doses even to  fertile flies. The resulting animals, though, 
exhibited an abdomen that resembled that of C. tentans rather than D. melanogaster because puparial contraction 
does not occur normally in chimeric USP-bearing mutants. 
 
Various chimeras made of D. melanogaster and B. mori EcR domains revealed the specific heterodimerization 
characteristics and differential ligand responsiveness of B. mori EcR to be localized in the D domain as well as 
in the E2 and E3 subdomains (Suhr et al., 1998). 
 
―Natural‖ chimeras of USP also exist. In crab (and tick), the heterodimer partner of EcR may be regarded as a 
chimera consisting of domains more closely related to an (insect) USP and an E domain exhibiting a higher 
degree of sequence homology to a (vertebrate) RXR (Chung et al., 1998; Guo et al., 1998). Accordingly, crabs 
respond to retinoids during regeneration. However, JH is also present in these types of animals obviously 
governing reproduction and the molting type (Laufer et al., 1993, and personal communication). 
 
CONCLUDING REMARKS 
The present review focused on just a few aspects of Ec receptor structure and function. Other aspects were not 
touched upon although they are or might turn out to be of significant importance as well. One of these future 
points certainly concerns phosphorylation (Rauch et al., 1998; Song and Gilbert, 1998). With regard to this 
point, we have just realized how important it might be. 
 
Acknowledgments: 
The unpublished work reported in this article has been supported by a grant of the Swiss Federal Institute of 
Technology, Zurich (to M.L.). 
 
The following colleagues provided us with information prior to publication, which is gratefully acknowledged: 
P. Lümmen, Frankfurt; L. I. Gilbert, Chapel Hill, NC; P. Hopkins, Norman, OK; K.-H. Tomaschko, Ulm; N. 
Seibel, Zürich; H. Laufer, Storrs, CT. 
 
Literature Cited: 
Ashburner M, Chihara C, Meltzer P, Richards G. 1974. Temporal control of puffing activity in polytene 
chromosomes. Cold Spring Harbor Symp Quant Biol 38: 655–662. 
Ashok M, Turner C, Wilson TG. 1998. Insect juvenile hormone resistance gene homology with the bHLH-PAS 
family of transcriptional regulators. Proc Natl Acad Sci USA 95:2761–2766. 
Beato M. 1989. Gene regulation by steroid hormones. Cell 56:335–344. 
Berger EM, Goudie K, Klieger L, Berger M, DeCato R. 1992. The juvenile hormone analogue, methoprene, 
inhibits ecdysterone induction of small heat shock protein gene expression. Dev Biol 151:410–418. 
Chung AC-K, Durica DS, Clifton SW, Roe BA, Hopkins PM. 1998. Cloning of crustacean EcR and RXR gene 
homologs and elevation of RXR mRNA by retinoic acid. Mol Cell Endocrinol 139:209–227. 
Crossland LD, Goff SA [Novartis]. 1996. Juvenile hormone or one of its agonists as chemical ligand to control 
gene expression in plants by receptor mediated transactivation. Int Patent Application Number 
PCT/EP96/ 04224. 
Dalman FC, Koenig RJ, Perdew GH, Massa E, Pratt WB. 1990. In contrast to the glucocorticoid receptor, the 
thyroid hormone receptor is translated in the DNA binding state and is not associated with hsp90. J Biol 
Chem 265:3615–3618. 
Elke C, Vögtli M, Spindler-Barth M, Lezzi M. 1997. Expression of EcR and USP in Escherichia coli: 
Purification and functional studies. Arch Insect Biochem Physiol 35:59–69. 
Feyereisen R. 1998. Juvenile hormone resistance: ¡ no  
PASaran ! Proc Natl Acad Sci USA 95:2725–2726. 
Gehring U. 1998. Steroid hormone receptors and heat shock proteins. Vitamins Hormones 54:167–205. 
Glass CK, Rose DW, Rosenfeld MG. 1997. Nuclar receptor coactivators. Curr Opin Cell Biol 9:222–232. 
Guo X, Qing X, Harmon MA, Jin X, Laudet V, Mangelsdorf DJ, Palmer MJ. 1998. Isolation of two functional 
retinoid X receptor subtypes from the ixodid tick, Amblyom m a am erican um (L.). Mol Cell Endocrinol 
13 9:45–60. 
Heery DM, Kalkhoven E, Hoare S, Parker MG. 1997. A signature motif in transcriptional coactivators mediates 
binding to nuclear receptors. Nature 387:733–736. 
Henrich VC, Rybczynski R, Gilbert LI. 1999. Peptide hormones, steroid hormones, and puffs: mechanisms and 
models in insect development. Vitamins Hormones 55:73–125. 
Jones G, Sharp PA. 1997. Ultraspiracle: an invertebrate nuclear receptor for the juvenile hormones. Proc Natl 
Acad Sci USA 94:13499–13503. 
Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman RA, Rose DW, Glass CK, 
Rosenfeld MG. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition 
by nuclear receptors. Cell 85:403–414. 
Laufer H, Ahl J SB, Sagi A. 1993. The role of juvenile hormones in crustacean reproduction. Am Zool 33:365–
374. 
Lezzi M. 1996. Chromosome puffing: Supramolecular aspects of ecdysone action. In: Gilbert LI, Tata JR, 
Atkinson BG, editors. Metamorphosis: postembryonic reprogramming of gene expression in amphibian 
and insect cells. San Diego: Academic Press. p 145–173. 
Lezzi M, Wyss C. 1976. The antagonism between juvenile hormone and ecdysone. In: Gilbert LI, editor. The 
juvenile hormones. New York: Plenum Publishing Corp. p 252–269. 
Lezzi M, Gatzka F, Ineichen H, Gruzdev AD. 1991. Transcriptional activation of puff site I-18C of Chironomus 
tentans: Hormonal responsiveness changes in parallel with diurnal decondensation cycle. Chromosoma 
100:235–241. 
Masuyama H, Brownfield CM, St-Arnaud R, MacDonald PN. 1997. Evidence for ligand-dependent 
intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator 
interaction. Mol Endocrinol 11:1507–1517. 
Montminy M. 1997. Something new to hang your HAT on. Nature 387:654–655. 
Rauch P, Grebe M, Elke C, Spindler K-D, Spindler-Barth M. 1998. Ecdysteroid receptor and Ultraspiracle from 
Chironomus tentans (Insecta) are phosphoproteins and are regulated differently by molting hormone. 
Insect Biochem Mol Biol 28:265–275. 
Rochette-Egly C, Adam S, Rossignol M, Egly J-M, Chambon P. 1997. Stimulation of RAR(x activation funtion 
AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 
90:97–107. 
Schulman IG, Shao G, Heyman RA 1998. Transcativation by retinoid X receptor-peroxisome proliferator-
activated receptor y(PPARy) heterodimers: Intermolecular synergy requires only PPARy hormone-
dependent activation function. Mol Cell Biol 18:3483–3494. 
Seibel N, Vögtli M, Elke C, Lezzi M. 1997. Immunoselection of genomic DNA sequences occupied by the 
EcR/USP complex. Hereditas 127:283. 
Shaaya E, Spindler K-D. 1990. The effect of methoprene on RNA and chitinolytic enzymes synthesis and on 
ecysteroid titer in some insects. In: Casida JE, editor. Pesticides and alternatives. Amsterdam: Elsevier. 
p 271–282. 
Song Q, Gilbert LI ,1998. Alterations in Ultraspiracle (USP) content and phosphorylation state accompanying 
feedback regulation of ecdysone synthesis in the insect prothoracic gland. Insect Biochem Mol Biol 
28:849–860. 
Song Q, Alnemri ES, Litwack G, Gilbert LI. 1997. An immunophilin is a component of the insect ecdysone 
receptor (EcR) complex. Insect Biochem Mol Biol 27:973–982. 
Stocker AJ, Amabis JM, Gorab E, Elke C, Lezzi M. 1997. Antibodies against the D-domain of a Chironomus 
ecdysone receptor protein react with DNA puff sites in Trichosia pubescens. Chromosoma 106:456–
464. 
Suhr ST, Gil EB, Senut M-C, Gage FH. 1998. High level transactivation by a modified Bombyx ecdysone 
receptor in mammalian cells without exogenous retinoid X receptor. Proc Natl Acad Sci USA 95:7999–
8004. 
Sutherland JD, Kozlov T, Tzertzinis G, Kafatos FC. 1995. Drosophila hormone receptor 3 8: A second partner 
for Drosophila USP suggests unexpected role for nuclear receptors of the nerve growth factor-induced 
protein B type. Proc Natl Acad Sci USA 92:7966–7970. 
Talbot WS, Swyryd EA, Hogness DS. 1993. Drosophila tissues with different metamorphic responses to 
ecdysone express different ecdysone receptor isoforms. Cell 73:1323–1337. 
Thomas HE, Stunneberg HG, Stewart AF. 1993. Heterodimerization of the Drosophila ecdysone receptor with 
retinoid X receptor and Ultraspiracle. Nature 362:471–475. 
Tomaschko K-H. 1999. Nongenomic effects of ecdysteroids. Arch Insect Biochem Physiol 41:89–98. 
Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG. 1997. The transcriptional co-
activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677–684. 
Torchia J, Glass C, Rosenfeld MG. 1998. Co-activators and co-repressors in the integration of transcriptional 
response. Curr Opin Cell Biol 10:373–383. 
Towers TL, Freedman LP. 1998. Granulocyte-macrophage colony-stimulating factor gene transcription is 
directly repressed by the vitamin D3 receptor. J Biol Chem 273:10338–10348. 
Turberg A, Spindler K-D. 1992. Properties of nuclear and cytosolic ecdysteroid receptors from an epithelial cell 
line from Chironomus tentans. J Insect Physiol 38: 81–91. 
Vivat V, Zechel C, Wurtz J-M, Bourguet W, Kagechika H, Umemiya H, Shudo K, Moras, D, Gronemeyer H, 
Chambon P. 1997. A mutation mimicking ligand-induced conformational change yields a constitutive 
RXR that senses allosteric effects in heterodimers. EMBO J 16:5697–5709. 
Vögtli M, Elke C, Imhof MO, Lezzi M. 1998. High level transactivation by the ecdysone receptor complex at 
the core recognition motif. Nucleic Acids Res 26:2407– 2414. 
Westin S, Kurokawa R, Nolte RT, Wisely GB, McInerney EM, Rose DW, Milburn MV, Rosenfeld MG, Glass 
CK.1998. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. 
Nature 395:199–202. 
White KP, Hurban P, Watanabe T, Hogness DS. 1997. Coordination of Drosophila metamorphosis by two 
ecdysone-induced nuclear receptors. Science 276:114–117. 
Wolffe AP. 1997. Sinful repression. Nature 387:16–17. 
Wong J, Li Q, Levi B-Z, Shi Y-B, Wolffe AP. 1997. Structural and functional features of a specific nucleosome 
containing a recognition element for the thyroid hormone receptor. EMBO J 16:130–145. 
Wurtz J-M, Bourguet W, Renaud J-P, Vivat V, Chambon P, Moras D, Gronemeyer H. 1996. A canonical 
structure for the ligand-binding domain of nuclear receptors. Nature Struct Biol 3:87–94 and 206. 
Yao T-P, Forman BM, Jiang Z, Cherbas L, Chen J-D, McKeow M, Cherbas P, Evans RM. 1993. Functional 
ecdysone receptor is the product of EcR and Ultraspiracle genes. Nature 366:476–479. 
Zelhof AC, Yao T-P, Chen JD, Evans RM, McKeown M. 1995. Seven-up inhibits Ultra spir acle-ba sed 
signaling pathways in vitro and in vivo. Mol Cell Biol 15:6736–6745. 
